Staging of Prostate Cancer and for Biochemical Recurrence-PSMA-PET/CT

Positron emission imaging (PET) of 68Ga-labelled prostate-specific membrane substance (68Ga-PSMA) is AN rising imaging modality introduced to assess the burden of adenocarcinoma, generally in biochemically repeated or advanced illness. 68Ga-PSMA PET provides the flexibility to by selection determine and localize pathologic process adenocarcinoma cells and afterwards modification patient management. attributable to its restricted history, sturdy sensitivity and specificity knowledge don’t seem to be accessible for 68Ga-PSMA PET–positive scans. 

Leave a Comment

Your email address will not be published.